Airway Pharmacology and Treatment 2019
DOI: 10.1183/13993003.congress-2019.pa2497
|View full text |Cite
|
Sign up to set email alerts
|

Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 0 publications
1
6
0
Order By: Relevance
“…In The findings of the evaluation of the PR programme in Crete (objective 6) are in accordance with international literature documenting the beneficial effects of PR for patients with CRDs (97,180). The documented pre-and post-PR differences in main clinical outcomes (CCQ and ISWT) were generally close to those observed in the development study of Uganda (99).…”
Section: Summary Of Findingssupporting
confidence: 84%
See 1 more Smart Citation
“…In The findings of the evaluation of the PR programme in Crete (objective 6) are in accordance with international literature documenting the beneficial effects of PR for patients with CRDs (97,180). The documented pre-and post-PR differences in main clinical outcomes (CCQ and ISWT) were generally close to those observed in the development study of Uganda (99).…”
Section: Summary Of Findingssupporting
confidence: 84%
“…PR is an evidence-based, non-medical, low-cost treatment intervention, proven effective in amending the systemic effects of lung disease, including breathlessness, inactivity and deconditioning (90). PR is recommended by international guidelines for patients with COPD (90,97,98).…”
Section: Promoting Affordable Treatment Options: Pulmonary Rehabilita...mentioning
confidence: 99%
“… 3 , 32 Taken together, these data suggest that more proactive evaluation of patients early in the course of their illness including spirometry might improve identification of patients at risk, earlier initiation of pharmacotherapies, and improved outcomes. 29 , 33 , 34 Additionally, although exacerbations are described as acute events, evidence indicates that significant risks following an exacerbation persist beyond the acute phase of the event. Therefore, the approach to managing COPD patients following an exacerbation should consider both immediate and longer-term risks.…”
Section: Discussionmentioning
confidence: 99%
“…COPD often develops gradually with no sharp onset date and is sometimes first diagnosed after the condition has progressed to the point of an exacerbation. 3 , 29 Further, a CV event can occur during an exacerbation. During our initial analyses, we identified 386 comparator patients and 49 exacerbation patients with an acute CV event on the same date as their incident COPD diagnosis.…”
Section: Methodsmentioning
confidence: 99%
“…3,4 Unfortunately, millions are living with COPD but have yet to be diagnosed. 5 The opportunity to diagnose COPD is generally missed in about 70% 3 and 85% 6 of adults. Younger age, identifying as woman, having a family history of COPD, not having a prior spirometry test, and living with a prior asthma diagnosis increases the risk of underdiagnosis in COPD.…”
Section: Introductionmentioning
confidence: 99%